[Drug therapy of atherosclerosis].
D000924:Anticholesteremic Agents / Q000627:therapeutic use*; D000925:Anticoagulants / Q000627:therapeutic use*; D001161:Arteriosclerosis / Q000188:drug therapy*; D002792:Cholestyramine Resin / Q000627:therapeutic use; D002994:Clofibrate / Q000627:therapeutic use; D004967:Estrogens / Q000627:therapeutic use; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D009539:Nicotinic Acids / Q000627:therapeutic use; D010743:Phospholipids / Q000627:therapeutic use; D013974:Thyroxine / Q000627:therapeutic use; D014665:Vasodilator Agents / Q000627:therapeutic use*
D000924:Anticholesteremic Agents; D000925:Anticoagulants; D004967:Estrogens; D009539:Nicotinic Acids; D010743:Phospholipids; D014665:Vasodilator Agents; D002792:Cholestyramine Resin; D006493:Heparin; D002994:Clofibrate; D013974:Thyroxine
Tratamentul medicamentos al aterosclerozei.